Regarding other abnormal features in models of AD, Aso et al. showed a reduction of neuroinflammation after intake of KD + triheptanoin in APP/PS1 mouse that was not observed in APP/PS1 mouse fed with KD only and thus might be specific to triheptanoin supplementation [17]. Here, APP is linked to Alzheimer disease.